Chinese English Japanese Korean

Nanjing JiuSiNuo Biopharmaceutical Technology Co., Ltd

Firmenname:Nanjing JiuSiNuo Biopharmaceutical Technology Co., Ltd
Telefon:-
E-Mail:chensheng870628@126.com
Nationalität:China
URL:
Produkte insgesamt:91
1

Produktkatalog

Brexpiprazole913611-97-9C25H27N3O2S
Ceritinib1032900-25-6C28H36ClN5O3S
lubiprostone333963-40-9C20H32F2O5
Riociguat625115-55-1C20H19FN8O2
Choline Fenofibrate856676-23-8C22H28ClNO5
TrifluridineTrifluridin70-00-8C10H11F3N2O5
Salbutamol34391-04-3C13H21NO3
Tafluprost209860-87-7C25H34F2O5
NA
Levalbuterol hydrochloride50293-90-8C13H22ClNO3
Revefenacin864750-70-9C35H43N5O4
SalbutaMon Hydrochloride41489-89-8C13H20ClNO3
Edoxaban (TsOH salt)480449-71-6C31H38ClN7O7S2
evocalcet870964-67-3C24H26N2O2
NA
NA
3-Furaldehyde498-60-2C5H4O2
NA
tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate1210348-34-7C16H29N3O7
Naloxone hydrochloride(5α)-17-Allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-onhydrochlorid357-08-4C19H22ClNO4
(5α,6α)-17-(CyclopropylMethyl)-4,5-epoxy-6-(MethylaMino)-Morphinan-3,14-diol102919-85-7C21H28N2O3
2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(2-furanyl)-N-methyl-, (E)- (9CI)152658-02-1C28H32N2O5
Naltrexone EP Impurity H503090-99-1C20H25NO4
NA
7,8-Dihydro-14-hydroxy- normorphinone(5α)-4,5-Epoxy-3,14-dihydroxymorphinan-6-on33522-95-1C16H17NO4
Cyclohexanecarboxamide, 4-bromo-3-hydroxy-N,N-dimethyl-, (1S,3S,4S)-1629245-79-9C9H16BrNO2
ZVPVPYWMFMUFEZ-UHFFFAOYSA-N909800-36-8C35H42N4O5
NA
6-BETA-NALTREXOL HCL49625-89-0C20H25NO4
162819-83-2162819-83-2C28H34N2O3
2-Propenamide, N-[(5α,6β)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-10-oxomorphinan-6-yl]-3-(3-furanyl)-N-methyl-, (2E)-1054312-73-0C28H30N2O6
tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate365998-36-3C14H27N3O3
Platinum(2+), diamminediaqua-, (SP-4-2)-, dinitrate52241-26-6H6N3O5Pt+
(1R,2R,4S)-2-[(tert-butoxycarbonyl)aMino]-4-[(diMethylaMino)carbonyl]cyclohexyl Methanesulfonate929693-31-2C15H28N2O6S
Deferasirox Isopropyl Ester1266741-29-0C24H21N3O4
DescyclopropylMethyl Nalfurafine163713-06-2C24H26N2O5
10α-Hydroxy-nalfurafine1054312-75-2C28H32N2O6
carbamic acid, n-[(1r,2r,5s)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]-, 1,1-dimethylethyl ester929693-30-1C14H26N2O4
(1S,3S,6R)-N,N-dimethyl-7-oxabicyclo[4.1.0]heptane-3-carboxamide929693-35-6C9H15NO2
Platinum, diamminedihydroxy[2-(hydroxy-κO)acetato(2-)-κO]-, (OC-6-44)-103436-60-8C2H6N2O5Pt
NA
Naltrexone 3-Methyl Ether16617-07-5C21H25NO4
Disalicylimide1972-71-0C14H11NO4
(1S,4S,5S)-4-Bromo-6-oxabicyclo[3.2.1]octan-7-one139893-81-5C7H9BrO2
Carbamic acid, N-[[[(1R,2R,5S)-5-[(dimethylamino)carbonyl]-2-hydroxycyclohexyl]amino]sulfonyl]-, 1,1-dimethylethyl ester1629245-68-6C14H27N3O6S
Nedaplatin95734-82-0C2H6N2O3Pt
NA
(5α,6β)-17-(CyclopropylMethyl)-4,5-epoxy-6-(MethylaMino)-Morphinan-3,14-diol102869-99-8C21H28N2O3
4H-1,3-Benzoxazin-4-one, 2-(5-chloro-2-hydroxyphenyl)-24798-50-3C14H8ClNO3
NA
Deferasirox Methyl Ester1266741-05-2C22H17N3O4
5-Aza-2'-deoxycytidine2353-33-5C8H12N4O4
(1S,3R,4R)-3-amino-4-hydroxy-N,N-dimethylcyclohexanecarboxamide929693-36-7C9H18N2O2
Edoxaban Impurity 16480450-69-9C14H25N5O3
Cyclohexanecarboxamide, 3-amino-4-hydroxy-N,N-dimethyl-, hydrobromide (1:1), (1S,3R,4R)-2964483-51-8C9H18N2O2.BrH
NA
NA
NA
3-(2-Furyl)acrylic acid3-(2-Furyl)acrylsure539-47-9C7H6O3
4H-1,3-Benzoxazin-4-one, 6-chloro-2-(2-hydroxyphenyl)-26276-85-7C14H8ClNO3
NA
azanide: dihydroxy-oxo-azanium: platinum(+4) cation: dihydroxide62048-58-2H8N5O5Pt2+
Palonosetron Hydrochloride135729-62-3C19H25ClN2O
Cabozantinib impurity 262840522-80-5C28H25ClFN3O5
Benzoic acid, 4-[5-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-1620154-59-7C21H14ClN3O4
PeMetrexed EP IMpurity C1802552-16-4C40H40N10O13
1,1-Cyclopropanedicarboxamide, N,N'-bis[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-2439164-91-5C39H34N4O8
1,3,5-Triazin-2(1H)-one, 4-amino-1-(2-deoxy-α-D-erythro-pentofuranosyl)-3,6-dihydro-114522-17-7C8H14N4O4
Platinum, diamminechloro(hydroxyacetato-O1)-, (SP-4-3)- (9CI)157176-10-8C2H7ClN2O3Pt
Deferasirox Impurity 8201530-78-1C21H15N3O4
PALONOSETRON HCL135729-75-8C19H24N2O
PeMetrexed EP IMpurity D144051-68-3C25H28N6O9
Pemetrexed Disodium150399-23-8C20H22N5NaO6
NA
Ilaprazole172152-36-2C19H18N4O2S
PeMetrexed EP IMpurity A869791-42-4C21H23N5O6
trans-Dichlorodiamineplatinum(II)Diammindichloroplatin14913-33-8Cl2H4N2Pt
EsoMeprazole related substance H431/411227380-90-6C16H15N3O4
Baloxavir marboxil1985606-14-1C27H23F2N3O7S
Esomeprazole119141-88-7C17H19N3O3S
2-Pyridinecarboxylic acid, 1,4-dihydro-5-methyl-4-oxo-1-[6-(1H-pyrrol-1-yl)-1H-benzimidazol-2-yl]-1508282-87-8C18H14N4O3
Naltrexone hydrochloride16676-29-2C20H24ClNO4
Cabozantinib849217-68-1C28H24FN3O5
PeMetrexed EP IMpurity E182009-04-7C20H21N5O6
Deferasirox Ethyl Ester201530-79-2C23H19N3O4
(E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide152658-36-1C28H32N2O5
Deferasirox201530-41-8C21H15N3O4
Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-(methylamino)-, (5α,6β)-, 1,2-benzenedicarboxylate (1:1)152657-10-8C29H34N2O7
PeMetrexed EP IMpurity B1802552-04-0C40H40N10O13
XGZZHZMWIXFATA-VQNNHZPYSA-N163712-68-3C28H32N2O5
Platinum (II), diammineoxalato-, cis-41349-15-9C2H4N2O4Pt
1
Copyright 2019 © ChemicalBook. All rights reserved